CLINICAL EVIDENCE • PATIENT SELECTION • IMPLANT PRACTICE

CHAIRS

BRADLEY P. KNIGHT, MD • LARRY A. CHINITZ, MD • THOMAS F. DEERING, MD

MICHAEL R. GOLD, MD, PHD – MUSC HEALTH, CHARLESTON SC

The role of autonomic modulation for the treatment of heart failure and the BAROSTIM NEO system mechanism of action.

MARWAN M. BAHU, MD FHRS – ABRAZO HEART, PHOENIX, AZ

BAROSTIM NEO Device Implantation Experience

KHALED A. AWAD, MD – MERCY HEART HOSPITAL, ST. LOUIS MS

Heart failure device treatment algorithm and BAROSTIM NEO patient selection

LUANDA GRAZETTE, MD, MPH – USC KECK HOSPITAL, SAN DIEGO, CA

Barostim Therapy Clinical Evidence